China Aoxing Pharmaceutical Company (CAXG.OB) received SFDA approval to begin a clinical trial of Tilidine/Naloxone capsules, a narcotic drug for moderate to severe pain (see story). The drug is given to alleviate cancer and post-surgical pain. China Aoxing plans to begin the clinical trial by the end of this year, and expects to receive final approval of the drug in 2011.
CAXG is currently tradin' at $1.30, my man
Seeking Alpha
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment